Immunic is trading at $7.42, up 6.15%, with the biotech sector’s 2.10% rise providing a possible tailwind. - The latest listed company announcement was the October 19 appointment of Jaa Roberson as Chief People Officer. - No company-specific October 20 catalyst appears in the available news results, and the exact cause of the larger move remains unclear.